Education
About Us
Working with TipRanks
Follow Us
RedHill Biopharma (RDHL)
NASDAQ:RDHL
See the Price Targets and Ratings of:
RDHL Financial Forecast
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
TipRanks
$2
Hold
66.67%
Upside
Reiterated
06/26/25
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
TipRanks
$2
Hold
66.67%
Upside
Reiterated
06/26/25
RDHL Analyst Recommendation Trends
Rating
Nov 21
Dec 21
Nov 22
Aug 24
Jun 25
Strong Buy
0
0
0
0
0
Buy
7
5
4
3
1
Hold
0
0
0
1
4
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
7
5
4
4
5
Each month's total comprises the sum of three months' worth of ratings.
RDHL Stock Forecast FAQ
What is RDHL’s average 12-month price target, according to analysts?
Based on analyst ratings, RedHill Biopharma’s 12-month average price target is 2.00.
What is RDHL’s upside potential, based on the analysts’ average price target?
RedHill Biopharma has 66.67% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is RDHL a Buy, Sell or Hold?
RedHill Biopharma has a consensus rating of Hold which is based on 0 buy ratings, 0 hold ratings and 0 sell ratings.
What is RedHill Biopharma’s price target?
The average price target for RedHill Biopharma is 2.00. This is based on 0 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $2.00 ,the lowest forecast is $2.00. The average price target represents 66.67% Increase from the current price of $1.2.
The highest analyst price target is $2.00 ,the lowest forecast is $2.00. The average price target represents 66.67% Increase from the current price of $1.2.
What do analysts say about RedHill Biopharma?
RedHill Biopharma’s analyst rating consensus is a Hold. This is based on the ratings of 0 Wall Streets Analysts.
How can I buy shares of RDHL?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.